James A Kaye Selected Research

norgestimate

7/2007	Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.
6/2006	Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
3/2006	Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35 microg of ethinyl estradiol.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

James A Kaye Research Topics

Disease

19	Neoplasms (Cancer) 01/2021 - 03/2004
11	Breast Neoplasms (Breast Cancer) 05/2021 - 09/2004
7	Skin Neoplasms (Skin Cancer) 01/2022 - 09/2004
6	Melanoma (Melanoma, Malignant) 01/2022 - 09/2004
6	Venous Thromboembolism 05/2010 - 06/2002
5	Prostatic Neoplasms (Prostate Cancer) 09/2020 - 06/2018
4	Lymphoma (Lymphomas) 01/2022 - 01/2018
4	Neutropenia 05/2021 - 01/2013
3	Pain (Aches) 05/2021 - 01/2018
3	Infections 01/2021 - 06/2010
3	Hodgkin Disease (Hodgkin's Disease) 01/2021 - 01/2013
3	Anemia 01/2021 - 10/2014
3	Sarcoma (Soft Tissue Sarcoma) 01/2018 - 01/2016
3	Disease Progression 01/2018 - 03/2012
3	Febrile Neutropenia 01/2018 - 01/2016
3	Colorectal Neoplasms (Colorectal Cancer) 01/2013 - 09/2004
3	Myocardial Infarction 11/2007 - 03/2005
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2021 - 01/2013
2	Hypertension (High Blood Pressure) 01/2021 - 03/2005
2	Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous) 01/2021 - 01/2018
2	Carcinoma (Carcinomatosis) 03/2020 - 03/2005
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 01/2014
2	Neoplasm Metastasis (Metastasis) 01/2019 - 01/2014
2	Overactive Urinary Bladder (Overactive Bladder) 06/2018 - 06/2017
2	Kaposi Sarcoma (Kaposi's Sarcoma) 01/2018 - 01/2018
2	Ovarian Neoplasms (Ovarian Cancer) 01/2018 - 01/2013
2	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2018 - 01/2018
2	Philadelphia Chromosome 02/2015 - 05/2012
2	Idiopathic Thrombocytopenic Purpura (Thrombocytopenic Purpura, Autoimmune) 06/2010 - 04/2009
2	Purpura 03/2004 - 01/2003
1	Parkinson Disease (Parkinson's Disease) 01/2022
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021
1	Fatigue 05/2021
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2021
1	Adenocarcinoma 03/2020
1	Multiple Myeloma 01/2020
1	Brain Neoplasms (Brain Tumor) 10/2019
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 08/2019
1	Spinal Cord Compression 01/2019
1	Bone Fractures (Bone Fracture) 01/2019
1	Squamous Cell Carcinoma of Head and Neck 09/2018
1	Atopic Dermatitis (Atopic Eczema) 01/2018
1	Basal Cell Carcinoma (Rodent Ulcer) 01/2017

Drug/Important Bio-Agent (IBA)

5	Oral ContraceptivesIBA 01/2010 - 06/2002
4	Pharmaceutical PreparationsIBA 06/2018 - 12/2003
3	pimecrolimus (Elidel)FDA Link 01/2021 - 01/2018
3	Tacrolimus (Prograf)FDA LinkGeneric 01/2021 - 01/2018
3	PlatinumIBA 03/2020 - 06/2015
3	Imatinib Mesylate (Gleevec)FDA Link 02/2015 - 03/2012
3	Inosine Triphosphate (ITP)IBA 06/2010 - 01/2003
3	Contraceptive Agents (Contraceptives)IBA 01/2010 - 03/2006
3	Ethinyl Estradiol (Estinyl)FDA LinkGeneric 01/2010 - 03/2006
3	norgestimate FDA LinkGeneric 07/2007 - 03/2006
2	CholesterolIBA 01/2022 - 03/2005
2	insulin receptor-related receptor (IRR)IBA 01/2022 - 01/2018
2	Hormones (Hormone)IBA 05/2021 - 01/2009
2	palbociclibIBA 05/2021 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 01/2018
2	oxybutynin (Tavor)FDA LinkGeneric 06/2018 - 06/2017
2	Solifenacin Succinate FDA Link 06/2018 - 06/2017
2	Tolterodine Tartrate (Detrol)FDA Link 06/2018 - 06/2017
2	darifenacin FDA Link 06/2018 - 06/2017
2	fesoterodine FDA Link 06/2018 - 06/2017
2	Muscarinic AntagonistsIBA 06/2018 - 06/2017
2	pegfilgrastim (Neulasta)FDA Link 01/2018 - 01/2016
2	Hemoglobins (Hemoglobin)IBA 10/2014 - 01/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2013 - 09/2005
2	Biomarkers (Surrogate Marker)IBA 05/2012 - 01/2012
2	Ortho Evra (Evra)FDA Link 05/2010 - 01/2010
2	Levonorgestrel (Plan B)FDA LinkGeneric 01/2010 - 06/2006
2	Progestins (Progestagens)IBA 01/2009 - 06/2006
2	rofecoxib (Vioxx)FDA Link 11/2007 - 10/2006
2	Celecoxib (Celebrex)FDA Link 11/2007 - 10/2006
2	Diclofenac (SR 38)FDA LinkGeneric 11/2007 - 10/2006
2	norelgestromin (LNGO)FDA Link 07/2007 - 03/2006
2	Tamoxifen FDA LinkGeneric 03/2005 - 09/2004
2	Measles-Mumps-Rubella Vaccine (MMR Vaccine)IBA 12/2003 - 01/2003
1	rasagiline (Azilect)FDA Link 01/2022
1	Biological ProductsIBA 01/2022
1	LipidsIBA 01/2022
1	ErbB Receptors (EGF Receptor)IBA 05/2021
1	Calcineurin InhibitorsIBA 01/2021
1	PENTAIBA 01/2020
1	selinexorIBA 01/2020
1	Octreotide (Sandostatin)FDA LinkGeneric 08/2019
1	lanreotide (Somatuline)FDA Link 08/2019
1	CrizotinibIBA 01/2019
1	AntiemeticsIBA 01/2018
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2018
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2018
1	olaratumabIBA 01/2018
1	InterferonsIBA 05/2017

Therapy/Procedure

22	Therapeutics 05/2021 - 03/2005
10	Drug Therapy (Chemotherapy) 10/2019 - 12/2003
4	Castration 09/2020 - 01/2019
4	Radiotherapy 01/2019 - 03/2011
2	Transdermal Patch 07/2007 - 03/2006
1	Cell- and Tissue-Based Therapy (Cell Therapy) 12/2021
1	Adjuvant Chemotherapy 01/2018
1	Emergency Treatment 12/2017